Topical corticosteroids early in bacterial keratitis may improve vision

Article

Research from the University of California, San Francisco, found that adding topical corticosteroids two to three days after starting topical antibiotics for the treatment of bacterial keratitis is linked to improved vision, according to a study recently published in JAMA Ophthalmology.

San Francisco-Research from the University of California, San Francisco, found that adding topical corticosteroids two to three days after starting topical antibiotics for the treatment of bacterial keratitis is linked to improved vision, according to a study recently published in JAMA Ophthalmology

The study assessed the timing of the administration of corticosteroids in a subgroup analysis of the Steroids for Corneal Ulcers Trial (SCUT), a randomized, double-masked, placebo-controlled trial that overall found no effect of adding topical corticosteroids to topical moxifloxacin hydrochloride in bacterial keratitis.

The researchers assessed the effect of topical corticosteroids (vs. placebo) on three-month best spectacle-corrected visual acuity in patients who received the treatment or placebo earlier (two to three days after starting topical antibiotics) vs. later (four days or later after starting topical antibiotics). The group also analyzed subgroups of patients with non-Nocardia keratitis and those with no topical antibiotic use before enrollment.

The patients who received the topical corticosteroids earlier had approximately one-line better visual acuity at three months than those given the placebo. In patients who were given the topical corticosteroids later had one-line worse visual acuity at three months compared to those in the placebo group.

The study states, “There may be a benefit with adjunctive topical corticosteroids if application occurs earlier in the course of bacterial corneal ulcers.”

Recent Videos
EnVision Summit Cochair Cecelia Koetting, OD, FAAO, Dipl ABO, says that attendees should get ready for more discussion-based panels at this year's conference.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
Bonnie An Henderson in an interview for the EnVision Summit
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
EnVision Summit cofounder and program chair Dr Bonnie Henderson chats about collaborative eye care
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Bonnie An Henderson in an interview for the EnVision Summit
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
© 2025 MJH Life Sciences

All rights reserved.